168 related articles for article (PubMed ID: 2949593)
1. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis.
Falk RH; Plehn JF; Deering T; Schick EC; Boinay P; Rubinow A; Skinner M; Cohen AS
Am J Cardiol; 1987 Feb; 59(5):418-22. PubMed ID: 2949593
[TBL] [Abstract][Full Text] [Related]
2. Amyloid cardiomyopathy: characterization by a distinctive voltage/mass relation.
Carroll JD; Gaasch WH; McAdam KP
Am J Cardiol; 1982 Jan; 49(1):9-13. PubMed ID: 6459025
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of cardiac amyloidosis and hypertrophic cardiomyopathy. A comparison of familial amyloidosis with polyneuropathy and hypertrophic cardiomyopathy by electrocardiography and echocardiography.
Eriksson P; Backman C; Eriksson A; Eriksson S; Karp K; Olofsson BO
Acta Med Scand; 1987; 221(1):39-46. PubMed ID: 3565084
[TBL] [Abstract][Full Text] [Related]
4. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart.
Cueto-Garcia L; Tajik AJ; Kyle RA; Edwards WD; Greipp PR; Callahan JA; Shub C; Seward JB
Mayo Clin Proc; 1984 Sep; 59(9):589-97. PubMed ID: 6471919
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis.
Rahman JE; Helou EF; Gelzer-Bell R; Thompson RE; Kuo C; Rodriguez ER; Hare JM; Baughman KL; Kasper EK
J Am Coll Cardiol; 2004 Feb; 43(3):410-5. PubMed ID: 15013123
[TBL] [Abstract][Full Text] [Related]
6. Cardiac amyloidosis masquerading as biventricular hypertrophy in a patient with multiple myeloma.
Basha HI; Raj E; Bachuwa G
BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23897372
[TBL] [Abstract][Full Text] [Related]
7. Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis.
Hamer JP; Janssen S; van Rijswijk MH; Lie KI
Eur Heart J; 1992 May; 13(5):623-7. PubMed ID: 1618203
[TBL] [Abstract][Full Text] [Related]
8. [Cardiac amyloidosis. Invasive and noninvasive diagnosis].
Pinamonti B; Dreas L; Bussani R; Mestroni L; Silvestri F; Tanganelli P; Camerini F
G Ital Cardiol; 1987 Dec; 17(12):1016-30. PubMed ID: 3503797
[TBL] [Abstract][Full Text] [Related]
9. [M-mode and two-dimensional echocardiography of 7 cases of cardiac amyloidosis].
Roudaut R; Haissaguerre M; Dallocchio M
Arch Mal Coeur Vaiss; 1984 Dec; 77(13):1525-31. PubMed ID: 6240237
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic criteria for diagnosis of left ventricular hypertrophy in the presence of complete right bundle branch block.
Vandenberg B; Sagar K; Paulsen W; Romhilt D
Am J Cardiol; 1989 May; 63(15):1080-4. PubMed ID: 2523183
[TBL] [Abstract][Full Text] [Related]
11. Cardiac amyloidosis--a case report.
Voon WC; Sheu SH; Hwang YY; Lee CS; Yen HW; Chang JS; Lin CC; Lai WT; Lin YT
Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Nov; 9(11):659-63. PubMed ID: 8046786
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic criteria of left ventricular hypertrophy in left bundle-branch block.
Cokkinos DV; Demopoulos JN; Heimonas ET; Mallios C; Papazoglou N; Vorides EM
Br Heart J; 1978 Mar; 40(3):320-4. PubMed ID: 147697
[TBL] [Abstract][Full Text] [Related]
13. Echocardiographic findings in amyloid cardiomyopathy.
Giles TD; León-Galindo J; Burch GE
South Med J; 1978 Nov; 71(11):1393-6. PubMed ID: 715489
[TBL] [Abstract][Full Text] [Related]
14. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
15. [Significance of electro- and echocardiogram for the diagnosis of cardial amyloidosis].
Klein HH
Dtsch Med Wochenschr; 1991 Jan; 116(1):13-7. PubMed ID: 1985799
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of technetium-99m-pyrophosphate scintigraphy in diagnosing cardiac amyloidosis.
Falk RH; Lee VW; Rubinow A; Hood WB; Cohen AS
Am J Cardiol; 1983 Mar; 51(5):826-30. PubMed ID: 6299087
[TBL] [Abstract][Full Text] [Related]
17. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy.
Murphy ML; Thenabadu PN; de Soyza N; Doherty JE; Meade J; Baker BJ; Whittle JL
Am J Cardiol; 1984 Apr; 53(8):1140-7. PubMed ID: 6230928
[TBL] [Abstract][Full Text] [Related]
18. Cardiac amyloidosis: combined use of two-dimensional echocardiography and electrocardiography in noninvasive screening before biopsy.
Sivaram CA; Jugdutt BI; Amy RW; Basualdo CA; Haraphongse M; Shnitka TK
Clin Cardiol; 1985 Oct; 8(10):511-8. PubMed ID: 4053429
[TBL] [Abstract][Full Text] [Related]
19. Three-dimensional Speckle Tracking Echocardiography in Light Chain Cardiac Amyloidosis: Examination of Left and Right Ventricular Myocardial Mechanics Parameters.
Urbano-Moral JA; Gangadharamurthy D; Comenzo RL; Pandian NG; Patel AR
Rev Esp Cardiol (Engl Ed); 2015 Aug; 68(8):657-64. PubMed ID: 26092748
[TBL] [Abstract][Full Text] [Related]
20. Clinical, electrocardiographic and echocardiographic findings in significant cardiac amyloidosis detected only at necropsy: comparison with cases diagnosed in life.
Gutierrez PS; Fernandes F; Mady C; Higuchi Mde L
Arq Bras Cardiol; 2008 Mar; 90(3):191-6. PubMed ID: 18392399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
